Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity
This event has passed.
March 30, 2023 @ 1:00 pm - 1:30 pm EDT
Tackling autoimmune diseases and conditions is dependent on understanding genetic and environmental mechanisms of disease and identifying treatments and interventions that work for everyone, regardless of sex, gender, race, or ethnicity. Therefore, recruiting and retaining a diversity of patient populations within clinical trials is essential. Yet, it is well-documented that certain populations — including women and racial and ethnic minority populations — have historically been underrepresented in clinical trials. While problematic in and of itself, underrepresentation can be particularly problematic for clinical trials for autoimmune diseases and conditions, which disproportionately affect women and specific racial groups.
During this SWHR Instagram Live event, experts discussed why clinical trial representation is critical for improving outcomes and where they see the greatest issues in trial participation.
Check out the full SWHR 2023 Autoimmune Policy series:
The Growing National Burden of Autoimmune Diseases and the Role of Policy in Improving Outcomes (January 17, 2023)
Coverage and Access Issues Affecting Women Living with Autoimmune Diseases (February 7, 2023)
The Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions (March 17, 2023)
Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity (March 30, 2023)
